Publications by authors named "Jacob R Shaw"

Claim this Profile
L
Lipid nanoparticles from Walp mitigate sepsis through multimodal protein corona formation.
Junsik J Sung, Jacob R Shaw, Josie D Rezende, Shruti Dharmaraj, Andrea L Cottingham

Mol Ther Methods Clin Dev· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microfluidics-generated PLA nanoparticles: impact of purification method on macrophage interactions, anti-inflammatory effects, biodistribution, and protein corona formation.
Jacob R Shaw, Radha Vaidya, Fanny Xu, Shruti Dharmaraj, Ryan M Pearson

RSC Pharm· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory disease progression shapes nanoparticle biomolecular corona-mediated immune activation profiles.
Jacob R Shaw, Nicholas Caprio, Nhu Truong, Mehari Weldemariam, Anh Tran

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid Nanoparticles from Walp Mitigate Sepsis through Multimodal Protein Corona Formation.
Junsik J Sung, Jacob R Shaw, Josie D Rezende, Shruti Dharmaraj, Andrea L Cottingham

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal nanoparticle-containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammation.
Nhu Truong, Andrea L Cottingham, Shruti Dharmaraj, Jacob R Shaw, Jackline Joy Martin Lasola

Bioeng Transl Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell and biomaterial delivery strategies to induce immune tolerance.
Brianna L Scotland, Jacob R Shaw, Shruti Dharmaraj, Nicholas Caprio, Andrea L Cottingham

Adv Drug Deliv Rev· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory Challenge.
Nhu Truong, Christopher C Goodis, Andrea L Cottingham, Jacob R Shaw, Steven Fletcher

ACS Pharmacol Transl Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis